Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 8, 2013, Pages 1353-1363

  Kabat, Geoffrey C ^a   Anderson, Matthew L ^d   Heo, Moonseong ^a   Hosgood, H Dean ^a   Kamensky, Victor ^a   Bea, Jennifer W ^e   Hou, Lifang ^f   Lane, Dorothy S ^b   Wactawski Wende, Jean ^c   Manson, JoAnn E ^g   Rohan, Thomas E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY HEIGHT; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MELANOMA; MULTICENTER STUDY (TOPIC); MULTIPLE MYELOMA; OVARY CANCER; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THYROID CANCER; WOMEN'S HEALTH;

AGED; BODY HEIGHT; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; UNITED STATES;

EID: 84882262124     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0305     Document Type: Article

References (52)

1. Batty GD, Shipley MJ, Langenberg C, Marmot MG, Davey Smith G. Adult height in relation to mortality from 14 cancer sites in men in London (UK): Evidence from the original Whitehall study. Ann Oncol 2006;17:157-66.
2. Sung J, Song Y-M, Lawlor DA, Davey Smith G, Ebrahim S. Height and site-specific cancer risk: A cohort study of a Korean adult population. Am J Epidemiol 2009;170:53-64.
3. Batty GD, Barzi F, Woodward M, Jamrozik K, Woo J, Kim HC, et al. Adult height and cancer mortality in Asia: The Asia Pacific Cohort Studies Collaboration. Ann Oncol 2010;21:646-54.
4. Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V. Height and cancer incidence in the Million Women Study: Prospective cohort, and meta-analysis of prospective studies of height and total cancer. Lancet Oncol 2011;12:785-94.
5. Kabat GC, Heo M, Kamensky V, Miller AB, Rohan TE. Adult height in relation to risk of cancer in a cohort of Canadian women. Int J Cancer 2012;132:1125-32.
6. The Emerging Risk Factors Collaboration. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: Individual participant meta-analysis. Int J Epidemiol 2012;41: 1419-33.
7. Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J,Holly JM. Height, leg length, and cancer risk: A systematic review. Epidemiol Rev 2001; 23:313-42.
8. Renehan AG. Height and cancer: Consistent link, but mechanisms unclear. Lancet Oncol 2011;12:716-7.
9. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. ControlClin Trials 1998;19:61-109.
10. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The Women's Health Initiative Observational Study: Baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 2003;13(9 Suppl):S107-21.
11. McTiernan A, Kooperberg C, White E, Wilcox S, Coates R, Adams-Campbell LL, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women: The Women's Health Initiative Cohort Study. JAMA 2003;290:1331-6.
12. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003;13(9 Suppl): S122-8.
13. Kabat GC, Heo M, Miller AB, Rohan TE. Scaling of weight for height in relation to risk of cancer at different sites in a cohort of Canadian women. Am J Epidemiol 2013;177:93-101.
14. Gail MH. Evaluating serial cancer marker studies in patients at risk of recurrent disease. Biometrics 1981;37:67-78.
15. Tulinius H, Sigusson N, Sigvaldason H, Bjarndottir K, Tryggvadottir L. Risk factors for malignant diseases: A cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 1997;6:863-73.
16. Okasha M, McCarron P, McEwen J, Davey Smith G. Height and cancer mortality: Results from the Glasgow University Student Cohort. Publ Health 2000;114:451-5.
17. Jousilahti P, Tuomilehto J, Vartiainen E, Eriksson J, Puska P. Relation of adult height to cause-specific and total mortality: A prospective follow-up study of 31,199 middle-aged men andwomen in Finland.Am J Epidemiol 2000;161:1112-20.
18. Park JY, Mitrou PN, Keogh RH, Luben RN, Wareham NJ, Khaw K-T. Self-reported and measured anthropometric data and risk of colorectal cancer in the EPIC-Norfolk study. Int J Obesity 2012;36: 107-18.
19. Olsen CM, Green AC, Zens MS, Stukel TA, Bataille V, Berwick M, et al. Anthropometric factors and risk of melanoma in women: A pooled analysis. Int J Cancer 2008;122:1100-8.
20. Schouten LJ, Rivera C, Hunter DJ, Spiegelman D, Adami HO, Arslan A, et al. Height, body mass index, and ovarian cancer: A pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 2008;17: 902-12.
21. White KK, Park S-Y, Kolonel LN, Henderson BE, Wilkens LR. Body size and breast cancer risk: The Multiethnic Cohort. Int J Cancer 2012;131: E705-16.
22. Hughes LAE, Simons CC, van den Brandt PA, Goldbohm RA, van Engeland M, WeijenbergMP. Body size and colorectal cancer risk after 16.3 years of follow-up: An analysis from the Netherlands Cohort Study. Am J Epidemiol 2011;174:1127-39.
23. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjønneland A, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:920-31.
24. Kabat GC, Kim MY, Thomson CA, Luo J, Wactawski-Wende J, Rohan TE. Anthropometric factors and physical activity and risk of thyroid cancer in postmenopausal women. Cancer Causes Control 2012;23:421-30.
25. Engeland A, Tretli S, Akslen LA, Bjørge T. Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer 2006;95: 366-70.
26. Batty GD, Shipley MJ, Gunnell D, Huxley R, Kivimaki M, Woodward M, et al. Height, wealth, and health: An overview with new data from three longitudinal studies. Econ Hum Biol 2009;7: 137-52.
27. Wadsworth ME, Hardy RJ, Paul AA, Marshall SF, Cole TJ. Leg and trunk length at 43 years in relation to childhood health, diet, and family circumstances: Evidence from the 1946 national birth cohort. Int J Epidemiol 2002;31:383-90.
28. Berkey CS, Colditz GA, Rockett RH, Frazier AL, Willett WC. Dairy consumption and female height growth: Prospective cohort study. Cancer Epidemiol Biomarkers Prev 2009;18:1881-7.
29. Ben Slomo Y, Holly J, McCarthy A, Savage P, Davies D, Gunnell D, et al. An investigation of fetal, postnatal and childhood growth with insulinlike growth factor 1 and binding protein 3 in adulthood. Clin Endocrinol (Oxf) 2003;59:366-73.
30. Martin RM, Holly JM, Gunnell D. Milk and linear growth: Programming of the IGF-I axis and implication for health in adulthood. In:Clemens RA, Hernell O, Michaelsen KF (eds), Milk and milk products in human nutrition. Nestle Nutrition Institute Workshop Series: Pediatric Program. vol. 67. Nestec Ltd., Vevey/S. Karger AG, Basel, Switzerland; 2011. p. 79-97.
31. Ish-Shalom D, Christoffersen CT, Vorwerk P, Sacerdoti-Sierra N, Naor D, De Meyts P. Mitogenic properties of insulin and insulin anologues mediated by the insulin receptor. Diabetologia 1997;40 Suppl 2:S25-S31.
32. Milazzo G, Giorgino F, Damante F, Sung C, Stampfer MR, Vigneri R, et al. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 1992;52:3924-30.
33. Clayton PE, Banerjee I, Murray PG, Renehan AG. Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol 2010;7:11-24.
34. Finstad SE, Emaus A, Tretli S, Jasienska G, Ellison PT, Furberg AS, et al. Adult height, insulin, and 17beta-estradiol in young women. Cancer Epidemiol Biomarkers Prev 2009;18:1477-83.
35. Albanes D, Winick M. Are cell number and cell proliferation risk factors for cancer. J Natl Cancer Inst 1988;80:772-4.
36. Lai C-Q. How much of human height is genetic and how much is due to nutrition? Scientific Am;Dec. 11, 2006 [cited 2013 June 24]. Available from: Http://www.scientificamerican.com/article.cfm?idhow-muchof-human- height&printtrue.
37. Lettre G. Recent progress in the study of the genetics of height. Hum Gen 2011;129:465-72.
38. Largo Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (letter) 2010;467:832-8.
39. Delahanty RJ, Beeghly-Fadiel A, Xiang YB, Long J, Cai Q, Wen W, et al. Association of obesity-related genetic variants with endometrial cancer risk: A report from the Shanghai Endometrial Cancer Genetics Study. Am J Epidemiol 2011;174:1115-26.
40. Yang J, Loos RJ, Powell JE, Medland SE, Speliotes EK, Chasman DI, et al. FTO genotype is associated with phenotypic variability of body mass index. Nature 2012;490:267-72.
41. Permuth-Wey J, Kim D, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, et al. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res 2011;71:3896-903.
42. West JA, Viswanathan SR, Yabuuchi A, Cunniff K, Takeuchi A, Park IH, et al. A role for Lin28 in primordial germ-cell development and germcell malignancy. Nature 2009;460:909-13.
43. El-Khairi R, Parnaik R, Duncan AJ, Lin L, Gerrelli D, Dattani MT, et al. Analysis of LIN28A in early human ovary development and as a candidate gene for primary ovarian insufficiency. Mol Cell Endocrinol 2012;351:264-8.
44. Elks CE, Perry JR, Sulem P, Chasman DI, Franceschini N, He C, et al. Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet 2010;42:1077-85.
45. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NFkappaB, Lin28, Let-7 microRNA, and IL6 links inflammation to cell transformation. Cell 2009;139:693-706.
46. Wu K, Jiao X, Li Z, Katiyar S, Casimiro MC, Yang W, et al. Cell fate determination factor Dachshund reprograms breast cancer stem cell function. J Biol Chem 2011;286:2132-42.
47. King CE, Cuatrecasas M, Castells A, Sepulveda AR, Lee JS, Rustgi AK. LIN28B promotes colon cancer progression and metastasis. Cancer Res 2011;71:4260-8.
48. Sakurai M, Miki Y, Masuda M, Hata S, Shibahara Y, Hirakawa H, et al. LIN28: A regulator of tumor-suppressing activity of let-7 microRNA in human breast cancer. J Steroid Biochem Mol Biol 2012;131:101-6.
49. Jiang X, Huang H, Li Z, Li Y, Wang X, Gurbuxani S, et al. Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLLassociated leukemia. Cancer Cell 2012;22:524-35.
50. Ke CC, Liu RS, Yang AH, Liu CS, Chi CW, Tseng LM, et al. CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy. Eur J Nucl Med Mol Imaging 2013;40: 61-71.
51. Oh JS, Kim JJ, Byun JY, Kim IA. Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys 2010;76:5-8.
52. Fagherazzi G, Vilier A, Boutron-Ruault M-C, Clavel-Chapelon F, Mesrine S. Height, sitting height, and leg length in relation to breast cancer risk in the E3N cohort. Cancer Epidemiol Biomarkers Prev 2012;21:1171-5.